# EDGAR Filing Document

**Accession Number:** 0001532215
**File Stem:** 0001532215-25-000006
**Filing Date:** 2025-11
**Character Count:** 7516
**Document Hash:** 55971dda3c7f66902f69c84c5180db1f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001532215-25-000006.hdr.sgml**: 20251118

**ACCESSION NUMBER**: 0001532215-25-000006

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251106

**FILED AS OF DATE**: 20251118

**DATE AS OF CHANGE**: 20251118

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Hibbert Paul
- **CENTRAL INDEX KEY:** 0001532215

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-15401
- **FILM NUMBER:** 251494913

**MAIL ADDRESS:**
- **STREET 1:** C/O EDGEWELL PERSONAL CARE COMPANY
- **STREET 2:** 6 RESEARCH DRIVE
- **CITY:** SHELTON
- **STATE:** CT
- **ZIP:** 06484
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** EDGEWELL PERSONAL CARE Co
- **CENTRAL INDEX KEY:** 0001096752
- **STANDARD INDUSTRIAL CLASSIFICATION:** PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 431863181
- **STATE OF INCORPORATION:** MO
- **FISCAL YEAR END:** 0930

**BUSINESS ADDRESS:**
- **STREET 1:** 6 RESEARCH DRIVE
- **CITY:** SHELTON
- **STATE:** CT
- **ZIP:** 06484
- **BUSINESS PHONE:** 203-944-5500

**MAIL ADDRESS:**
- **STREET 1:** 6 RESEARCH DRIVE
- **CITY:** SHELTON
- **STATE:** CT
- **ZIP:** 06484

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ENERGIZER HOLDINGS INC
- **DATE OF NAME CHANGE:** 19991013

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Hibbert Paul<br><sub>(Last) (First) (Middle)</sub><br>C/O EDGEWELL PERSONAL CARE COMPANY<br>6 RESEARCH DRIVE<br><sub>(Street)</sub><br>SHELTON, CT 06484<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-11-06 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Supply Chain Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>EDGEWELL PERSONAL CARE Co [ EPC ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-11-13 |  | M<sup>(1)</sup> |  | 5773 | A | $0 | 49015.693 | D |  |
| Common Stock | 2025-11-13 |  | F |  | 2676<sup>(2)</sup> | D | $18.39 | 46399.693 | D |  |
| Common Stock | 2025-11-13 |  | M<sup>(3)</sup> |  | 4149 | A | $0 | 50488.693 | D |  |
| Common Stock | 2025-11-13 |  | F |  | 1924<sup>(2)</sup> | D | $18.39 | 48564.6930 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Performance Stock Equivalents 11-11-2022 | $0 | 2025-11-13 |  | M |  |  | 5773 | 2025-11-13<sup>(1)</sup> | <sup>(1)</sup> | Common Stock | 5773 | $0 | 0 | D |  |
| Performance Stock Equivalents 11-8-2024 | $0 | 2025-11-06 |  | A |  | 4149 |  | 2025-11-13<sup>(3)</sup> | <sup>(3)</sup> | Common Stock | 4149 | $0 | 4149 | D |  |
| Performance Stock Equialents 11-8-2024 | $0 | 2025-11-13 |  | M |  |  | 4149 | 2025-11-13<sup>(3)</sup> | <sup>(3)</sup> | Common Stock | 4149 | $0 | 0 | D |  |
| Restricted Stock Equivalents 11-14-2025 | $0 | 2025-11-14 |  | A |  | 15445 |  | 2026-11-14<sup>(4)</sup> | <sup>(4)</sup> | Common Stock | 15445 | $0 | 15445 | D |  |

---

### Footnotes:

(1) Each Performance Stock Equivalent ("PSE") is convertible into one share of common stock of Edgewell Personal Care Company ("EPC").  The performance conditions with respect to 5,773 PSEs were satisfied and vested into EPC common stock on November 13, 2025.  The remaining 10,580 PSEs did not satisfy the necessary performance conditions and were canceled on the same date.

(2) Reflects shares withheld as payment of a tax liability upon vesting of PSEs.

(3) Reflects an award of PSEs for which the performance conditions were satisfied on November 6, 2025 and remaining time vesting conditions were satisfied on November 13, 2025.  Each PSE is convertible into shares of EPC common stock.

(4) Each Restricted Stock Equivalent ("RSE") is convertible into one share of EPC common stock.  The award of RSEs shall vest as to one-third of the original grant of 15,445 RSEs on each of the first three anniversaries of the grant date.

**Signature:** /s/ Paul Hibbert  
**Date:** 2025-11-18

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**